SCHEMBL9097352

SCHEMBL9097352

CCOC(=O)CC(c1ccccn1)c1c(C)cc2cc(OC)coc1-2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
FGFR2 P21802 3/20 0.38
FGFR3 P22607 2/20 0.38
FGFR1 P11362 1/20 0.38
FGFR4 P22455 1/20 0.38
KDR P35968 1/20 0.38
PTPN1 P18031 2/20 0.36
LMNA P02545 1/20 0.35
MAPT P10636 5/20 0.35
ALDH1A1 P00352 6/20 0.34
KDM4E B2RXH2 6/20 0.34
HPGD P15428 3/20 0.34
TP53 P04637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CASP1 P29466 1/20 0.34
SLC16A3 O15427 1/20 0.34
SLC16A1 P53985 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7550096 0.76 MTNR1A (0.46) GAAMEN1KMT2ASMN1; SMN2FGFR2
SCHEMBL9587136 0.71 MEN1 (0.44) GAAMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL5929583 0.70 SMN1; SMN2 (0.56) GAAMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL313449 0.70 SMN1; SMN2 (0.56) GAAMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL9097726 0.70 RAB9A (0.47) MEN1KMT2ASMN1; SMN2LMNAMAPT
SCHEMBL9587127 0.69 MEN1 (0.46) GAAMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL7548098 0.67 SMN1; SMN2 (0.47) GAAMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL2300693 0.67 MEN1 (0.40) GAAMEN1KMT2ASMN1; SMN2FGFR2
SCHEMBL1077616 0.67 SMN1; SMN2 (0.55) GAAMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL1051991 0.67 SMN1; SMN2 (0.55) GAAMEN1KMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0482108-B1 SUBSTITUTED 2-IMIDAZOLINES AND PREPARATION AND USE THEREOF NOVO NORDISK AS (DK) 1996-03-20 EP disclosed
US-5262430-A Antidiabetic agent lowers blood glucose in mammals in type 2 non insulin dependent diabetes NOVO NORDISK A/S (DK) 1993-11-16 US disclosed